Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | ADORA2B | P29275 | 1/20 | 0.39 |
| ▸ | ACHE | P22303 | 1/20 | 0.34 |
| ▸ | GDA | Q9Y2T3 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.32 |
| ▸ | HPGD | P15428 | 1/20 | 0.32 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.32 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
| ▸ | XDH | P47989 | 3/20 | 0.31 |
| ▸ | ENPP1 | P22413 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3085104 | 0.76 | LMNA (0.52) | MAPTADORA2BACHEGDAALDH1A1 | |
| SCHEMBL8884684 | 0.75 | MAPT (0.47) | MAPTADORA2BACHEGDAALDH1A1 | |
| SCHEMBL6555062 | 0.75 | MAPT (0.52) | MAPTADORA2BACHEGDAALDH1A1 | |
| SCHEMBL7221071 | 0.72 | MAPT (0.49) | MAPTADORA2BACHEGDAALDH1A1 | |
| SCHEMBL11642909 | 0.72 | MAPT (0.44) | MAPTADORA2BACHEGDAALDH1A1 | |
| Ethylene SCHEMBL30877093 | 0.71 | MAPT (0.43) | MAPTADORA2BACHEGDAALDH1A1 | |
| SCHEMBL28870894 | 0.71 | ADORA2B (0.44) | MAPTADORA2BACHEGDAALDH1A1 | |
| SCHEMBL31265613 | 0.68 | MAPT (0.40) | MAPTADORA2BACHEGDAALDH1A1 | |
| SCHEMBL18285100 | 0.67 | MAPT (0.39) | MAPTADORA2BACHEGDAALDH1A1 | |
| Potassium SCHEMBL30877092 | 0.67 | ALDH1A1 (0.47) | MAPTADORA2BALDH1A1HPGDHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0811623-B1 | Xanthine derivatives with end-aminated alkynol side chains | HOECHST AG (DE) | 2001-04-04 | — | — | EP | disclosed |
| US-5965555-A | TREATMENT AND/OR PROPHYLAXIS OF CEREBROVASCULAR DISORDERS CHARACTERIZED BY DAMAGE CAUSED BY ISCHEMIA AND SUBSEQUENT NECROTIC DESTRUCTION OF NERVE CELLS(NEURONS) | HOECHST AKTIENGESELLSCHAFT (DE) | 1999-10-12 | — | — | US | disclosed |
| EP-0811623-A1 | Xanthine derivatives with end-aminated alkynol side chains | HOECHST AKTIENGESELLSCHAFT (DE) | 1997-12-10 | — | — | EP | disclosed |